Non-small cell lung cancer Trials in Dallas, United States
Conditions / Non-small cell lung cancer / Dallas, United States
Non-small cell lung cancer has been the subject of sustained clinical investigation across multiple research sites.
174 total trials for this combination
Showing top 10 of 174 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04913337 | Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2 |
| NCT06695845 | A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors | RECRUITING | PHASE2 |
| NCT04068896 | Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy | COMPLETED | PHASE1/PHASE2 |
| NCT02391480 | A Study Evaluating the Safety and Pharmacokinetics of ABBV-075 in Subjects With Cancer | COMPLETED | PHASE1 |
| NCT04803305 | Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia | COMPLETED | PHASE1 |
| NCT03735680 | A Study to Evaluate ONM-100, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer | COMPLETED | PHASE2 |
| NCT02628535 | Safety Study of MGD009 in B7-H3-expressing Tumors | TERMINATED | PHASE1 |
| NCT03452774 | SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry | RECRUITING | — |
| NCT04585750 | The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) | RECRUITING | PHASE1/PHASE2 |
| NCT02568267 | Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) | ACTIVE_NOT_RECRUITING | PHASE2 |